Clinical features and treatment interventions for human immunodeficiency virus-associated neurologic disease in children

Seminars in Neurology

Volumn 19, Issue 2, 1999, Pages 165-176

  Mintz, Mark ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b Children's Hosp Philadelphia S   (United States)

Author keywords

Acquired immunodeficiency syndrome; AIDS; Children; HIV; Human immunodeficiency virus type 1; Neurobehavioral; Neurologic disease; Opportunistic infection; Pediatric; Progressive encephalopathy; Psychiatric

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROLOGIC DISEASE; NUTRITIONAL DEFICIENCY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 0032857357     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040834     Document Type: Review

References (111)

1. Association Francois-Xavier Bagnoud, www.fxb.org
2. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989;321:1791-1796
3. Douglas GC, King BF. Maternal-fetal transmission of human immunodeficiency virus: A review of possible routes and cellular mechanisms of infection. Clin Infect Dis 1992;15:678-691
4. Oxtoby MJ. Vertically acquired HIV infection in the United States. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS. Baltimore: Williams & Wilkins, 1994:1-20
5. Hein K, Dell R, Futterman D, et al. Comparison of HIV+and HIV-adolescents: Risk factors and psychosocial determinants. Pediatrics 1995;95:96-104
6. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991;253:37-42
7. Grubman S, Gross E, Lerner-Weiss N, et al. Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. Pediatrics 1995;95:657-663
8. Epstein LG, Sharer LR, Oleske JM, et al. Neurologic manifestations of HIV infection in children. Pediatrics 1986;78:678-687
9. Belman AL, Diamond G, Dickson D, et al. Pediatric acquired immunodeficiency syndrome: Neurologic syndromes. Am J Dis Child 1988;142:29-35
10. Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991;41:778-785
11. Sharer LR, Mintz M. Neuropathology of AIDS in children. In: Scaravilli F, ed. AIDS - the pathology of the nervous system. Berlin: Springer-Verlag, 1993:201-214
12. Mintz M. Clinical comparison of adult and pediatric NeuroAIDS. Adv Neuroimmunol 1994;4:207-221
13. Mintz M. Clinical features of HIV infection in children. In: Gendelman HE, Lipton S, Epstein L, et al. eds. The neurology of AIDS. New York: Chapman and Hall/International Thomson Publishing, 1998:385-407
14. Cooper ER, Hanson C, Diaz C, et al. Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants transmission Study Group. J Pediatr 1998;132:808-812
15. Blanche S, Mayaux M-J, Rouzioux C, et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994;330:308-312
16. Blanche S, Tardieu M, Duliege AM, et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection: Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child 1990;144:1210-1215
17. Pratt RD, Nichols S, McKinney N, et al. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children. J Infect Dis 1996;174:288-293
18. Galli L de Martino M, Tovo PA, Gabiano C, et al. Onset of clin signs in children with HIV-1 perinatal infection. AIDS 1995;9:455-461
19. Lyman WD, Kress Y, Kure K, et al. Detection of HIV in fetal central nervous system tissue. AIDS 1990;4:917-920
20. Working Group on Antiretroviral Therapy and Medical Management of Infants, Children and Adolescents with HIV Infection. Antiretroviral therapy and medical management of pediatric HIV infection. Pediatrics 1998;102(Suppl):1005-1062
21. The European Collaborative Study. Neurologic signs in young children with human immunodeficiency virus infection. Pediatric Infect Dis J 1990;9:402-406
22. Sharer LR, Epstein LG, Cho E-S, et al. Pathologic features of AIDS encephalopathy in children: Evidence for LAV/HTLV-III infection of brain. Hum Pathol 1986;17:271-284
23. DeCarli C, Civitello L, Brouwers P. et al. The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immunodeficiency virus. Ann Neurol 1993;34;198-205
24. Wolters PL, Brouwers P, Moss HA, et al. Differential receptive and expressive language functioning of children with symptomatic HIV disease and relation to CT scan brain abnormalities. Pediatrics 1995;95:112-119
25. Aylward EH, Henderer JD, McArthur JC, et al. Reduced basal ganglia volume in HIV-1-associated dementia. Neurology 1993;43:2099-2104
26. Jernigan TL, Archibald S, Hesselink JR, et al. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. Arch Neurol 1993;50:250-255
27. Brouwers P, DeCarli D, Civitello L, et al. Correlation between computed tomographic brain scan abnormalities and neuropsychological function in children with symptomatic human immunodeficiency virus disease. Arch Neurol 1995;53:39-44
28. Scarmato V, Frank Y, Rozenstein A, et al. Central brain atrophy in childhood AIDS encephalopathy. AIDS 1996;10:1227-1231
29. Mintz M, Tardieu M, Hoyt L, et al. Levodopa therapy improves motor function in HIV-infected children. Neurology 1996;47:1583-1585
30. Epstein LG, DiCarlo FJ, Jashi VV, et al. Primary lymphoma of the central nervous system in children with acquired immunodeficiency syndrome Pediatrics 1988;82:355-363
31. Park YD, Belman AL, Kim T-S, et al. Stroke in pediatric acquired immunodeficiency syndrome. Ann Neurol 1990;28:303-311
32. Kugler SL, Barzilai A, Hodes DS, et al. Acute hemiplegia associated with HIV infection. Pediatr Neurol 1991;7:207-210
33. Frank Y, Lim W, Kahn E, et al. Multiple ischemic infarcts in a child with AIDS, varicella zoster infection, and cerebral vasculitis. Pediatr Neurol 1989;5:64-67
34. Pressman H. Communication disorders and dysphagia in pediatrie AIDS. ASHA 1992;34:45-47
35. Raphael SA, de Leon G, Sapin J. Symptomatic primary human immunodeficiency virus infection of the brain stem in a child [letter]. Pediatr Infect Dis J 1989;8:654-656
36. Brouwers P, Tudor-Williams G, DeCarli C, et al. Relation between stage of disease and neurobehavioral measures in children with symptomatic HIV disease. AIDS 1995;9:713-720
37. Nozyce M, Hittelman J, Muenz L, et al. Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics 1994;94:883-891
38. Wilkins JW, Robertson KR, van der Horst C, et al. The importance of confounding factors in the evaluation of neuropsychological changes in patients infected with human immunodeficiency virus. J Acquir Immun Defic Syndr 1990;3:938-942
39. Mintz M. Neurological and developmental problems in pediatric HIV infection. J Nutr 1996;126(Suppl):S2663-S2673
40. Hanna J, Mintz M. Neurological and neurodevelopmental functioning in pediatric HIV infection. In: Boyd-Franklin N, Steiner GL, Boland M, eds. Children, families and HIV/AIDS: Psychosocial and psychotherapeutic issues. New York: Guilford Press, 1995:30-50
41. Whitt JK, Hooper SR, Tennison MB, et al. Neuropsychologic functioning of human immunodeficiency virus-infected children with hemophilia. J Pediatr 1993;122:52-59
42. Mitchell WG, Lynn H, Bale JF, et al. Longitudinal neurological follow-up of a group of HIV-seropositive and HIV-seronegative hemophiliacs: Results from the hemophilia growth and development study. Pediatrics 1997;100:817-824
43. Frank Y, Pavlakis S, Black K, et al. Reversible occipital parietal encephalopathy syndrome in AIDS. Neurology 1998;51:915-916
44. Mintz M, McSherry G. Hoyt LG, et al. Wernicke's encephalopathy in a child with HIV infection. Clinical Neuropathology, 1993. Presented at the Neuroscience of HIV Infection: Basic and Clinical Frontiers 1993, Vienna, Austria, June 1993
45. Sharer LR, Mintz M, Vinters HV, et al. Vacuolar myelopathy in children with AIDS. Presented to the IV International Conference on Neuroscience of HIV Infection: Basic and Clinical Frontiers 1992. Amsterdam, Holland, July 15, 1992
46. Sharer LR, Dowling PC, Michaels J, et al. Spinal cord disease in children with HIV-1 infection: A combined molecular biological and neuropathological study. Neuropathol Appl Neurobiol 1990;16:317-331
47. Dickson DW, Belman AL, Kim TS, et al. Spinal cord pathology in pediatric acquired immunodeficiency syndrome. Neurology 1989;39:227-235
48. Jay C, Dalakas MC. Myopathies and neuropathies in HIV-infected adults and children. In: Wilfert CM, Pizzo PA, eds. Pediatric AIDS: The challenge of HIV infection in infants, children, and adolescents. Baltimore: Williams & Wilkins, 1994
49. Floeter MK, Civitello LA, Everett CR, et al. Peripheral neuropathy in children with HIV infection. Neurology 1997;49:207-212
50. Walter EB, Drucker RP, McKinney RE, et al. Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy. J Pediatr 1991;119:152-155
51. Dalakas MC, Illa I, Pezeshkpour GH, et al. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990;322:1098-1105
52. Semino-Mora MC, Leon-Monzon ME, Dalakas MC. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I. L-Carnitine prevents the myotoxicity of AZT in vitro. Lab Invest 1994;71:102-112
53. Mintz M. Carnitine in HIV/AIDS. J Child Neurol 1995;10(Suppl 2):S40-S44
54. Wolters PL, Brouwers P. Evaluation of neurodevelopmental deficits in children with HIV infection. In: Gendelman HE, Lipton S, Epstein L, et al., eds. The neurology of AIDS. New York: Chapman and Hall/International Thomson Publishing, 1998:425-442
55. Hernandez M, Barros J. A new challenge in children with HIV: Psychosis [abstract]. Presented at the Seventh Annual Conference of the Association of Nurses in AIDS Care, Nashville, Tennessee, November 10-12, 1994
56. Hirschfeld S, Laue L, Cutler GB Jr, et al. Thyroid abnormalities in children infected with human immunodeficiency virus. J Pediatr 1996;128:70-74
57. Brouwers P, Moss H, Wolters P, et al. Neurobehavioral typology of school-age children with symptomatic HIV disease [abstract]. J Clin Exp Neuropsychol 1992;14:113
58. Brouwers P, van der Vlugt H, Moss H. et al. White matter changes on CT brain scan are associated with neurobehavioral dysfunction in children with symptomatic HIV disease. Child Neuropsychol 1995;1:93-105
59. Haiken H, Hernandez M, Mintz M. School-aged HIV-infected children and access to education. Pediatr AIDS HIV Infect 1991;2:74-79
60. Cohen-Addad N, Joshi V, Sharer L. Congenital acquired immunodeficiency syndrome and congenital toxoplasmosis: Pathologic support for a chronology of events. J Perinatol 1988;3: 328-331
61. 1997 USPHS/IDSA. Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1997;46:1-46
62. Leggiadro RJ, Kline MW, Hughes WT. Extrapulmonary cryptococcosis in children with AIDS. Pediatr Infect Dis J 1991; 10:658-662
63. Jue S, Whitley RJ. Herpesvirus infections in children with human immunodeficiency virus. In: Wilfert CM, Pizzo PA, eds. Pediatric AIDS: The challenge of HIV infection in infants, children, and adolescents. Baltimore: Williams & Wilkins, 1994: 348-364
64. Vandersteenhoven JJ, Dhaibo G, Boyko OB, et al. Progressive multifocal leukoencephalopathy in pediatric acquired immunodeficiency syndrome. Pediatr Infect Dis J 1992;11:232-237
65. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Evaluation and management of intracranial mass lesions in AIDS. Neurology 1998;50:21-26
66. Morriss MC, Rutstein RM, Rudy B. et al. Progressive multifocal leukoencephalopathy in an HIV-infected child. Neuroradiology 1997;39:142-144
67. Marra CM. Syphilis and human immunodeficiency virus infection. Semin Neurol 1992;12:43-50
68. Gutman LT, Moye J, Zimmer B, et al. Tuberculosis in human immunodeficiency virus-exposed or infected United States children. Pediatr Infect Dis J 1994;13:963-968
69. Clifford DB. Neurologic complications of human immunodeficiency virus infection. Neurologist 1998;4:54-65
70. Butterworth RF, Gaudreau C, Vincelette J, et al. Thiamine deficiency and Wernicke's encephalopathy in AIDS. Metab Brain Dis 1991;6:207-212
71. Beach RS, Morhan R, Wilkie F, et al. Plasma vitamin B12 level as a potential cofactor in studies of human immunodeficiency virus type 1-related cognitive changes. Arch Neurol 1992;49: 501-506
72. Dowling S, Lambe J, Mulcahy F. Vitamin B12 and folate status in human immunodeficiency virus infection. Eur J Clin Nutr 1993;47:803-807
73. McKinney RE, Maha MA, Connor EM, et al. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. N Engl J Med 1991;324:1018-1025
74. Periquet BA, Jammes NM, Lambert WE, et al. Micronutrient levels in HIV-1 infected children. AIDS 1995;9:887-893
75. Anonymous. Maternal vitamin A deficiency is associated with increased mother-to-child transmission of the human immunodeficiency virus (HIV). Nutr Rev 1994;52:281-282
76. Semba RD, Graham NM, Caiaffa WT, et al. Increased mortality associated with vitamin A deficiency during human immunodefciency virus type 1 infection. Arch Intern Med 1993;153: 2149-2154
77. Pavlakis SG, Lu D, Frank Y, et al. Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy. Am J Neuroradiol 1998;19:383-385
78. Epstein LG, Goudsmit J, Paul DA, et al. Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy. Ann Neurol 1987;21:397-401
79. Zaknum D, Orav J, Kornegay J, et al. Correlation of ribonucleic acid polymerase chain reaction, acid dissociated p24 antigen, and neopterin with progression of disease: A retrospective, longitud nal study of vertically acquired human immunodefciency virus type 1 infection in children. J Pediatr 1997;130: 898-905
80. Mintz M, Rapaport TR, Oleske JM, et al. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child 1989;143:771-774
81. Perrella O, Carrieri PB, Guarnaccia D, et al. Cerebrospinal fluid cytokines in AIDS dementia complex. J Neurol 1992;239:387-388
82. Wesselingh SL, Power C, Glass JD, et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993;33:576-582
83. McArthur JC, Nance-Sproson TE, Griffin DE, et al. The diagnostic utility of elevation in cerebrospinal fluid beta-2-microglobulin in HIV-1 dementia. Neurology 1992;42:1707-1712
84. Heyes MP, Brew BJ, Martin A, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: Relationship to clinical and neurological status. Ann Neurol 1991;29:202-209
85. Grimaldi LM, Martino GV, Franciotta DM, et al. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol 1991;29:21-25
86. Brew BJ, Bhalla RB, Paul M, et al. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol 1990;28:556-560
87. Frank Y, Vishnubhakat SM, Pahwa S. Brainstem auditory evoked responses in infants and children with AIDS. Pediatr Neurol 1992;8:262-266
88. Tinuper P, de Carolis P, Galeotti M, et al. Electroencephalogram and HIV infection: A prospective study in 100 patients. Clin Electroencephalogr 1990;21:145-150
89. Vigliano P, Russo R, Arfelli P, et al. Diagnostic value of multimodal evoked potentials in HIV-1 infected children. Neurophysiol Clin 1997;27:283-292
90. Mintz M, Connor EM, Oleske JM, et al. Neurologic deterioration in children on long-term zidovudine therapy. Presented at the Ninth AIDS Clinical Trials Group Meeting, Bethesda, Maryland, July 10-13, 1990
91. Brouwers P, Moss H, Wolters P, et al. Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. J Pediatr 1990;117:980-985
92. Tudor-Williams G, St. Clair M, McKinney RE, et al. HIV-1 sensitivity to zidovudine and clinical outcome in children. Lancet 1992;339:15-19
93. Sei S, Stewart SK, Farley M, et al. Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy. J Infect Dis 1996;174:1200-1206
94. Englund JA, Baker CJ, Raskino C, et al. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med 1997;336:1704-1712
95. Tepper VJ, Farley JJ, Rothman MI, et al. Neurodevelopmental/neuroradiologic recovery of a child infected with HIV after treatment with combination antiretroviral therapy using the HIV-specific protease inhibitor ritonavir. Pediatrics 1998;101:E7
96. American Academy of Pediatrics Committee on Infectious Diseases. Health guidelines for the attendance in day-care and foster care settings of children infected with human immunodeficiency virus. Pediatrics 1987;79:466
97. Hirschfeld S, Moss H, Dragisic K, et al. Pain in pediatric human immunodeficiency virus infection: Incidence and characteristics in a single-institution pilot study. Pediatrics 1996;98:449-452
98. French GM, Painter EC, Coury DL. Blowing away shot pain; a technique for pain management during immunization. Pediatrics 1994;93:384-388
99. Miser AW, Goh TS. Dose AM, et al. Trial of a topically administered local anesthetic (EMLA cream) for pain relief during central venous port accesses in children with cancer. J Pain Sympt Manage 1994;9:259-264
100. Herzlich BC, Schiano TD. Reversal of apparent AIDS dementia complex following treatment with vitamin B12. J Intern Med 1993;233:495-497
101. Bottiglieri T, Hyland K. S-adenosylmethionine levels in psychiatric and neurological disorders: A review. Acta Neurol Scand 1994;154(Suppl): 19-26
102. Castagna A, Le Grazie C, Accordini A, et al. Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection: Effect of parenteral treatment with SAMe. Neurology 1995;45:1678-1683
103. Stiehm ER, Bryson YJ, Frenkel LM, et al. Prednisone improves human immunodeficiency virus encephalopathy in children. Pediatr Infect Dis J 1992;11:49
104. Spiegel L, Mayers A. Psychosocial aspects of AIDS in children and adolescents. Pediatr Clin North Am 1991;38:153-167
105. Hriso E, Kuhn T, Masdeu JC, et al. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. Am J Psych 1991;148:1558-1561
106. Holmes VF, Fernandez F, Levy JK. Psychostimulant responses in AIDS-related complex patients. J Clin Psych 1989;50:5
107. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-1180
108. Centers for Disease Control and Prevention. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994;43: 1-20
109. Hersh BS, Popovici F, Apetrei RC, et al. Acquired immunodeficiency syndrome in Romania. Lancet 1991;338:645-649
110. Mintz M, Boland M, O'Hara M-J, et al. Pediatric HIV infection in Elista, Russia: Interventional strategies. Am J Public Health 1995;85:586-588
111. Keller SE, Bartlett JA, Schleifer SJ, et al. HIV-relevant sexual behavior among a healthy inner-city heterosexual adolescent population in an endemic area of HIV. J Adolesc Health Care 1991;12:44-48